Indiana
Fee-For-Service Medicaid Coverage of Screening
Covered
Highlighted Disparity
No racial disparities were found in Indiana for these lung cancer metrics.
Lung Cancer Rates
New Cases:
- The rate of new lung cancer cases in Indiana is not available over this period due to the impact of COVID-19 on cancer surveillance in 2020.
5-Year Survival Rate:
- The percent of people still alive five years after being diagnosed with lung cancer (the survival rate) is 26.6% nationally. Indiana is one of the 9 states for which survival data is not available as they do not track cases after diagnosis.
Early Diagnosis:
- The early diagnosis rate is not available for Indiana due to the impact of COVID-19 on cancer surveillance in 2020.
Lung Cancer Treatment
Surgical Treatment:
- Nationally, 20.8% of cases undergo surgery as part of the first course of treatment. Data on surgery as part of the first course of treatment is not available for Indiana due to the impact of COVID-19 on cancer surveillance in 2020.
Lack of Treatment:
- Nationally, 20.6% of cases receive no treatment. Data on surgery as part of the first course of treatment is not available for Indiana due to the impact of COVID-19 on cancer surveillance in 2020.
Screening
Screening for High Risk:
- In Indiana, 5.1% of those at high risk were screened, which was significantly higher than the national rate of 4.5%.
- It ranks 24th among all states, placing it in the average tier.
- Actual screening rates may be higher in states with large, regional managed care providers that did not share screening data.
Medicaid Coverage:
- Indiana was one of the 49 states whose Medicaid fee-for-service programs covered lung cancer screening as of October 2023.
Prevention
Tobacco Use:
- The smoking rate in Indiana is 17.3% and significantly higher than the national rate of 13.5%.
- It ranks 44th among all states, placing it in the below average tier.
Radon:
- In Indiana, 40.2% of radon tests results were at or above the action level recommended by EPA.
- It ranks 40th among all states, placing it in the below average tier.
Racial & Ethnic Disparities
Black individuals:
- Lung cancer rates are not available for Indiana due to the impact of COVID-19 on cancer surveillance in 2020.
Latino individuals:
- Lung cancer rates are not available for Indiana due to the impact of COVID-19 on cancer surveillance in 2020.
Asian Americans or Pacific Islanders:
- Lung cancer rates are not available for Indiana due to the impact of COVID-19 on cancer surveillance in 2020.
Indigenous Peoples:
- Lung cancer rates are not available for Indiana due to the impact of COVID-19 on cancer surveillance in 2020.
Summary
Early diagnosis data is not available for Indiana. When this rate increases, we can anticipate that the surgery rate would increase, as surgery is often the recommended treatment for those diagnosed at an earlier stage. In addition, when cases are found earlier, we would expect the five-year survival rate to increase.
The Lung Association encourages all states to cover lung cancer screening based on the latest guidelines across all fee-for-service and managed care plans without any financial or administrative barriers in their Medicaid programs.